Shenmiao Yang

3PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Sep 13, 2022
Is unmeasurable residual disease (uMRD) the best surrogate endpoint for clinical trials, regulatory approvals and therapy decisions in chronic lymphocytic leukaemia (CLL)?

Shenmiao Yang, Neil E Kay, Min Shi

|Sep 28, 2021
Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both?

Shenmiao Yang, Neil E Kay, Min Shi

|Jul 02, 2021
Will New Drugs Replace Transplants for Chronic Lymphocytic Leukaemia?

Shenmiao Yang, Xiaojun Huang, Robert Peter Gale

Pageof 1

Frequent Collaborators

2 joint publications

Neil E Kay

2 joint publications

Min Shi

2 joint publications

Robert Peter Gale

1 joint publications

Roland B Walter